【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 11
2 Introduction 12
2.1 Spinal Fusion Overview 12
3 Products under Development 13
3.1 Spinal Fusion – Pipeline Products by Stage of Development 13
3.2 Spinal Fusion – Pipeline Products by Segment 14
3.3 Spinal Fusion – Pipeline Products by Territory 15
3.4 Spinal Fusion – Pipeline Products by Regulatory Path 17
3.5 Spinal Fusion – Pipeline Products by Estimated Approval Date 18
3.6 Spinal Fusion – Ongoing Clinical Trials 19
4 Spinal Fusion – Pipeline Products under Development by Companies 20
4.1 Spinal Fusion Companies – Pipeline Products by Stage of Development 20
4.2 Spinal Fusion – Pipeline Products by Stage of Development 22
5 Spinal Fusion Companies and Product Overview 26
5.1 4-Web Spine, LLC Company Overview 26
5.1.1 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.2 Alphatec Holdings, Inc. Company Overview 30
5.2.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Amedica Corporation Company Overview 41
5.3.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
5.4 APTO Orthopaedics Company Overview 43
5.4.1 APTO Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview 43
5.5 Aurora Spine Corporation Company Overview 44
5.5.1 Aurora Spine Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
5.6 Bio2 Technologies, Inc. Company Overview 49
5.6.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 Bonovo Orthopedics, Inc. Company Overview 51
5.7.1 Bonovo Orthopedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.8 Cortical Concepts (Inactive) Company Overview 53
5.8.1 Cortical Concepts (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.9 DiFusion Technologies Inc. Company Overview 54
5.9.1 DiFusion Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.10 ECA Medical Instruments, Inc. Company Overview 56
5.10.1 ECA Medical Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 Eden Spine, LLC Company Overview 58
5.11.1 Eden Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.12 Eminent Spine, LLC Company Overview 63
5.12.1 Eminent Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.13 Exactech, Inc. Company Overview 66
5.13.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.14 Expanding Orthopedics Inc. Company Overview 68
5.14.1 Expanding Orthopedics Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.15 Globus Medical, Inc. Company Overview 72
5.15.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.16 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 76
5.16.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.17 Implants International Limited Company Overview 77
5.17.1 Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.18 Integra LifeSciences Holdings Corporation Company Overview 79
5.18.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.19 Intelligent Implant Systems, LLC Company Overview 81
5.19.1 Intelligent Implant Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.20 Intrinsic Therapeutics, Inc. Company Overview 83
5.20.1 Intrinsic Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.21 Jemo Spine, LLC. Company Overview 86
5.21.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 86
5.22 Kspine, Inc. Company Overview 87
5.22.1 Kspine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.23 Medtronic plc Company Overview 88
5.23.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 88
5.24 MicroPort Scientific Corporation Company Overview 92
5.24.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 92
5.25 Nasseo, Inc. Company Overview 95
5.25.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.26 NLT SPINE Company Overview 96
5.26.1 NLT SPINE Pipeline Products & Ongoing Clinical Trials Overview 96
5.27 NuVasive, Inc. Company Overview 99
5.27.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.28 OsteoGeneX Inc. Company Overview 104
5.28.1 OsteoGeneX Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.29 OsteoVantage, Inc. Company Overview 107
5.29.1 OsteoVantage, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.30 Paradigm Spine, LLC Company Overview 108
5.30.1 Paradigm Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
5.31 Pharmaco-Kinesis Corporation Company Overview 109
5.31.1 Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.32 Spinal Balance Inc. Company Overview 110
5.32.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.33 Spinal Simplicity, LLC Company Overview 113
5.33.1 Spinal Simplicity, LLC Pipeline Products & Ongoing Clinical Trials Overview 113
5.34 SpinalVu Inc Company Overview 114
5.34.1 SpinalVu Inc Pipeline Products & Ongoing Clinical Trials Overview 114
5.35 Spine Smith, LP Company Overview 116
5.35.1 Spine Smith, LP Pipeline Products & Ongoing Clinical Trials Overview 116
5.36 Spine Wave, Inc. Company Overview 118
5.36.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
5.37 SpineAlign Medical, Inc. Company Overview 119
5.37.1 SpineAlign Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
5.38 SpineCraft, LLC Company Overview 120
5.38.1 SpineCraft, LLC Pipeline Products & Ongoing Clinical Trials Overview 120
5.39 SpineGuard, S.A. Company Overview 122
5.39.1 SpineGuard, S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Spineology Inc. Company Overview 124
5.40.1 Spineology Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.41 Spineway Company Overview 127
5.41.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 127
5.42 Spinofix Inc Company Overview 129
5.42.1 Spinofix Inc Pipeline Products & Ongoing Clinical Trials Overview 129
5.43 The University of Utah Company Overview 133
5.43.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 University of South Florida Company Overview 134
5.44.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Vexim SA Company Overview 138
5.45.1 Vexim SA Pipeline Products & Ongoing Clinical Trials Overview 138
5.46 X-spine Systems, Inc. Company Overview 141
5.46.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141
5.47 Zyga Technology, Inc. Company Overview 142
5.47.1 Zyga Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
6 Spinal Fusion – Recent Developments 145
7 Appendix 250
7.1 Methodology 250
7.2 About GlobalData 252
7.3 Contact Us 253
7.4 Disclaimer 253
【レポート販売概要】
■ タイトル:脊椎固定装置の世界市場:パイプラインレビュー2015■ 英文:Spinal Fusion - Pipeline Review, 2015
■ 発行日:2015年4月28日
■ 調査会社:GlobalData
■ 商品コード:GDME0007EPD
■ 調査対象地域:グローバル
- NFV(ネットワーク機能の仮想化)市場:事例、市場分析、2014-2019予測)(The Network Functions Virtualization (NFV) Market: Business Case, Market Analysis & Forecasts 2014 – 2019)Network Functions Virtualization (NFV) is a telecom led initiative that aims to utilize standard IT virtualization technology to consolidate many telco network equipment types onto industry standard high volume servers, switches and storage. NFV involves implementing network functions in software that can run on a range of industry standard server hardware, and that can be moved to, or instantiate …
- 世界のポリイソブチレン(PIB)市場2015The Global Polyisobutylene (PIB) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Polyisobutylene (PIB) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Polyisobutylene (PIB) market analysis is provided for the international markets including deve …
- 二輪車用ABSの世界市場About Two-wheeler Anti-Braking System (ABS)The objective of ABS is to stop the vehicle without locking the wheels. ABS offer the braking force in pulses and allows the vehicle to come to a gradual halt, reducing the possibility of skidding, and reduces the braking distance. Technavio’s analysts forecast the global two-wheeler anti-braking system (ABS) market to grow at a CAGR of 59.75% during the …
- マスターバッチの世界市場:ホワイトマスターバッチ、ブラックマスターバッチ、カラーマスターバッチ、添加剤マスターバッチ、フィラーマスターバッチThe masterbatch market is projected to reach USD 12.61 Billion by 2020, registering a CAGR of 7.0% between 2015 and 2020. The global masterbatch market is driven by increased demand from the end-use industries such as packaging, building & construction, consumer goods, automotive, and textiles. Asia-Pacific, with its growing economy and rapidly expanding commercial and industrial base is projected …
- 世界のCAE(Computer-aided Engineering)市場動向(2012-2016)Introduction to the market Computer-aided engineering (CAE) is the practice of using a broad range of software products to assist in engineering tasks. These software products support a wide range of tasks such as the simulation, validation, analysis, and manufacture of engineering products. CAE includes two major tools-finite element analysis (FEA) and computational fluid dynamics (CFD). FEA is a …
- マルチパラメータ患者モニタの世界市場About Multiparameter Patient Monitoring Equipment Multiparameter patient monitoring equipment is a monitoring system that measures and displays the waveforms and numerical data for patients. It is helpful in the diagnosis of disorders/diseases as well as in the treatment of patients in various healthcare settings. This monitoring system is capable of measuring a variety of vital patient parameters …
- オフショア石油・ガス生産の世界市場:浅海掘削、深海掘削About Offshore Oil and Gas Offshore oil and gas production refers to the oil and gas extraction process that takes place mostly in the seabed and oceans. Oil and gas are extracted from the wells and transferred through ships and pipelines to refineries. With the increased depletion of onshore oil and gas resources, offshore resources experienced a greater demand in the supply of oil and gas. The g …
- 仮想加入者宅内機器(vCPE)の世界市場2019-2023About this market The advantages of vCPE in IoT implementation is one of the key factors expected to trigger the market’s growth in the forthcoming years. vCPE offers the required infrastructure for IoT implementation for virtualizing the network functions. It also helps in speeding up the deployment of network infrastructure and reduction of operational costs. As a result, the increased demand fo …
- 環境試験の世界市場予測(~2022年):標本、汚染物質、技術、地域別分析The environment testing market is estimated to be valued at USD 9.03 Billion in 2017 and is projected to reach USD 12.75 Billion by 2022, at a CAGR of 7.1% from 2017. The market is driven by increasing regulations pertaining to environment protection, cost- & time-effective customized testing services, and active participation of government and regulatory bodies to monitor environmental conditions …
- 世界の溶媒蒸発市場:蒸発器種類別(ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器)、エンドユーザー別(医薬&バイオ医薬品、診断研究所、研究所&学術研究所)、地域別“The global solvent evaporators market size is projected to grow at a CAGR of 7.3%.” The global solvent evaporators market size is expected to reach USD 694 million by 2024 from an estimated USD 487 million in 2019, at a CAGR of 7.3%. The growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large mol …
- 世界におけるバイオメトリック(生体認証)システム市場2013-2023(市場トレンド、開発状況、課題)Synopsis This report offers readers insights into technological developments in the Biometric System market, as well as detailed analysis of the changing preferences of military forces around the world. It also identifies the current trends in the changing industry structure and the challenges faced by industry participants. Summary Technological Developments in the global Biometric System include …
- Remicade(クローン病治療薬):市場予測及び分析(~2022)Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety a …
- 燃料添加剤の世界市場2015-2019Technavio's market research analyst estimates the global fuel additives market to witness a steady growth at a rate of around 8% during the forecast period. The adoption of ethanol and biodiesel is expected to drive the market growth for fuel additives due to the usage of antioxidants, corrosion inhibitors, cold flow improvers, and other products. The rise in the adoption of hybrid electric vehicl …
- 心血管情報システム(CVIS)の世界市場予測(~2024年)“The China cardiology information system market is projected to register a CAGR of 8.9% during the forecast period.”The China cardiology information system market is projected to reach USD 54 million by 2024 from USD 35 million in 2019, at a CAGR of 8.9%. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of cardiovascular disease, an in …
- リアルタイム位置情報管理システム(RTLS)の世界市場予測(~2022):提供形態別(ハードウェア、ソフトウェア、サービス)、技術別(RFID、W-Fi、UWB、BLE、赤外線)、用途別、産業別、地域別The real-time locating systems market was valued at USD 1.42 Billion in 2015 and is expected to reach USD 8.09 Billion by 2022, at a CAGR of 24.5% during the forecast period. The requirement for resource utilization and workflow optimization in several industries, rising market competitiveness, increasing technological advancements, and high return on investment are the major drivers for the this …